Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To investigate the evolution of the 18F-deoxyglucose (FDG) uptake and the tumour
characteristics determined in the plasma of patients with rectal cancer during and after
radiotherapy or combined radiotherapy and chemotherapy.
The changes of the FDG uptake of the primary tumour and the evolution of key tumour
characteristics during radiotherapy alone or in combination with chemotherapy will be
predictive for the pathological tumour response.
Study hypothesis The changes of the FDG uptake of the primary tumour and the evolution of key
tumour characteristics during radiotherapy alone or in combination with chemotherapy will be
predictive for the pathological tumour response.